{
    "Question": "Resmed CES 2024 product highlight and specification",
    "Summary": "ResMed Inc.\n\nCES 2024 Product Highlight:\n\n- Strong revenue growth driven by ongoing patient flow and solid demand across global sleep and respiratory care markets\n- Increasing adoption of outside hospital software solutions\n- Best-in-class AirSense 11 platform driving growth in Europe, Asia, and beyond\n- Introduction of AI-driven software products into the digital health ecosystem\n- New patient starts on physician and provider-facing platform, AirView, and patient-facing app, myAir, showing strong patient flow\n- Goal of improving 250 million lives by 2025\n\nFor more information, visit ResMed.com or follow @ResMed.",
    "Summary_cn": "ResMed股份有限公司。\n\nCES 2024产品亮点：\n- 持续的病人流量和全球睡眠和呼吸护理市场的稳定需求推动的强劲收入增长\n- 在院外软件解决方案的采用不断增加\n- 领先的AirSense 11平台在欧洲、亚洲和其他地区带动增长\n- AI驱动的软件产品进入数字健康生态系统\n- 医生和供应商面向平台AirView和病人面向应用程序myAir上新的病人启动显示出强劲的病人流量\n- 目标是到2025年改善2.5亿人的生活\n\n有关更多信息，请访问 ResMed.com 或关注@ResMed。"
}